News & Updates

Galcanezumab shows sustained efficacy, CV safety in migraine

05 May 2021 by

Not only does the CGRP* inhibitor galcanezumab show sustained efficacy in migraine patients, long-term treatment does not come with excess cardiovascular (CV) risk, according to studies presented at the AAN 2021 Annual Meeting.

Galcanezumab shows sustained efficacy, CV safety in migraine

05 May 2021

Morphine drip delivers cardioprotection in acute myocardial infarction

05 May 2021 by

Administering intravenous morphine prior to primary percutaneous coronary intervention cuts myocardial and microvascular damage in patients with acute myocardial infarction (AMI), as shown in the MonAMI trial.

Morphine drip delivers cardioprotection in acute myocardial infarction

05 May 2021

High protein/carbs diet elevates atherosclerotic CVD risk in adults

05 May 2021

Unhealthful dietary patterns, such as “fast food” and “high carbohydrate and protein,” positively correlate with atherosclerotic cardiovascular disease (ASCVD) risk and cardiovascular age gap (CAG), a study in Canada has shown.

High protein/carbs diet elevates atherosclerotic CVD risk in adults

05 May 2021

Overactive bladder puts damper on hypertension management in men

05 May 2021

In the management of hypertension, men with overactive bladder are less likely to achieve blood pressure control than their peers who do not have the urological condition, according to a study.

Overactive bladder puts damper on hypertension management in men

05 May 2021

Dapagliflozin cuts CV events even in sickest kidney disease patients

03 May 2021 by

The SGLT2 inhibitor (SGLT2i) dapagliflozin consistently reduces cardiovascular (CV) events regardless of baseline kidney function and albuminuria status in patients with type 2 diabetes (T2D) — with the greatest absolute benefit in those with most severe kidney disease, according to a prespecified secondary analysis of the DECLARE-TIMI* 58 trial.

Dapagliflozin cuts CV events even in sickest kidney disease patients

03 May 2021

RAS inhibitors more renoprotective than CCBs in advanced chronic kidney disease

03 May 2021 by

In the treatment of patients with advanced chronic kidney disease, use of renin-angiotensin system (RAS) inhibitors slows the progression of kidney disease compared with calcium channel blockers (CCBs), although the two drugs offer similar cardiovascular protection, as shown in a study.

RAS inhibitors more renoprotective than CCBs in advanced chronic kidney disease

03 May 2021

OSA tied to higher risk of atrial fibrillation, stroke in morbidly obese patients

01 May 2021

Morbidly obese patients are more likely to have atrial fibrillation and stroke in the presence of obstructive sleep apnoea (OSA), a study suggests.

OSA tied to higher risk of atrial fibrillation, stroke in morbidly obese patients

01 May 2021

Catheter ablation outshines pharmacotherapy in AF patients with heart failure

30 Apr 2021 by

Among atrial fibrillation (AF) patients with clinically defined heart failure, catheter ablation yields greater survival gains, freedom from AF recurrence, and quality of life boost than does drug therapy, according to the results of the CABANA AF* substudy.

Catheter ablation outshines pharmacotherapy in AF patients with heart failure

30 Apr 2021

Certain biologics for psoriasis may reduce cardiometabolic burden

30 Apr 2021

In the treatment of patients with psoriasis, use of certain biologic drugs appears to reduce aortic vascular inflammation and cardiometabolic risk biomarkers, including C-reactive protein and interleukin-6, according to a study.

Certain biologics for psoriasis may reduce cardiometabolic burden

30 Apr 2021

Favourable score in AHA’s Life's Simple 7 tied to lower NAFLD prevalence

29 Apr 2021 by

Higher cardiovascular health score in the American Heart Association (AHA)-defined Life’s Simple 7 (LS7) is associated with a lower prevalence of nonalcoholic fatty liver disease (NAFLD), reports a study, suggesting the potential of LS7 in the prevention of liver disease.

Favourable score in AHA’s Life's Simple 7 tied to lower NAFLD prevalence

29 Apr 2021

News & Updates

Filter by Specialty:

Specialty:

Galcanezumab shows sustained efficacy, CV safety in migraine

Galcanezumab shows sustained efficacy, CV safety in migraine

Morphine drip delivers cardioprotection in acute myocardial infarction

Morphine drip delivers cardioprotection in acute myocardial infarction

High protein/carbs diet elevates atherosclerotic CVD risk in adults

High protein/carbs diet elevates atherosclerotic CVD risk in adults

Overactive bladder puts damper on hypertension management in men

Overactive bladder puts damper on hypertension management in men

Dapagliflozin cuts CV events even in sickest kidney disease patients

Dapagliflozin cuts CV events even in sickest kidney disease patients

RAS inhibitors more renoprotective than CCBs in advanced chronic kidney disease

RAS inhibitors more renoprotective than CCBs in advanced chronic kidney disease

OSA tied to higher risk of atrial fibrillation, stroke in morbidly obese patients

OSA tied to higher risk of atrial fibrillation, stroke in morbidly obese patients

Catheter ablation outshines pharmacotherapy in AF patients with heart failure

Catheter ablation outshines pharmacotherapy in AF patients with heart failure

Certain biologics for psoriasis may reduce cardiometabolic burden

Certain biologics for psoriasis may reduce cardiometabolic burden

Favourable score in AHA’s Life's Simple 7 tied to lower NAFLD prevalence

Favourable score in AHA’s Life's Simple 7 tied to lower NAFLD prevalence